Cancer protein and drug complex. Molecular model showing imatinib drug molecules (sticks) bound to and inhibiting the active sites of the Bcr-Abl fusi

---

Cancer protein and drug complex. Molecular model showing imatinib drug molecules (sticks) bound to and inhibiting the active sites of the Bcr-Abl fusion protein that causes chronic myeloid leukaemia.

---

Size: 3624px × 4831px
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: abl, active, artwork, atp, bcr, bcr-abl, binding, biochemical, biochemistry, body, bound, cancer, cancerous, chemical, chemicals, chromosome, chronic, cml, drug, drugs, fusion, genetic, genetics, gleevec, glivec, healthcare, human, imatinib, inhibited, inhibiting, inhibition, inhibitor, inhibitors, leukaemia, leukemia, medical, medicine, model, molecular, molecule, molecules, myelogenous, myeloid, oncogene, oncological, oncology, pharmacological, pharmacology, philadelphia, protein, proteins, proteomics, site, structure, treatment